CLOSTRIDIUM DIFFICILE IMMUNOGENE ZUSAMMENSETZUNG

Patent europeic · EP3160500 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3160500
Numer da la dumonda
EP15733404
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
25-06-2015
Publitgà
03-05-2017
Concedì
21-08-2019
La protecziun finescha il pli tard
24-06-2035
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61K 39/08 (2006.01)
C07K 14/33 (2006.01)
Prioritad
GB 201411306 25.06.2014
GB 201411371 26.06.2014
Dumonda PCT
PCT/EP2015/064324 25.06.2015
Publicaziun PCT
WO2015/197737 30.12.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 12-09-2019

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 12.09.2019

  7. 21-08-2019

    Concedì

    Published in Swissreg on 21.08.2019

Partidas

Possessur

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

CASTADO, Cindy

B-1330 Rixensart, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.